Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 1
2009 4
2010 6
2011 3
2012 6
2013 2
2014 1
2015 3
2016 1
2017 3
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O, Giulio Favalli E, Becciolini A, Benucci M, Gobbi FL, Guiducci S, Foti R, Mosca M, Goletti D. Cantini F, et al. Among authors: kaloudi o. Semin Arthritis Rheum. 2017 Oct;47(2):183-192. doi: 10.1016/j.semarthrit.2017.03.008. Epub 2017 Mar 22. Semin Arthritis Rheum. 2017. PMID: 28413099 Review.
Uveitis in Spondyloarthritis: An Overview.
Cantini F, Nannini C, Cassarà E, Kaloudi O, Niccoli L. Cantini F, et al. Among authors: kaloudi o. J Rheumatol Suppl. 2015 Nov;93:27-9. doi: 10.3899/jrheum.150630. J Rheumatol Suppl. 2015. PMID: 26523051 Review.
Infliximab in psoriatic arthritis.
Cantini F, Niccoli L, Nannini C, Kaloudi O, Cassarà E. Cantini F, et al. Among authors: kaloudi o. J Rheumatol Suppl. 2012 Jul;89:71-3. doi: 10.3899/jrheum.120249. J Rheumatol Suppl. 2012. PMID: 22751598 Review.
Psoriatic arthritis: a systematic review.
Cantini F, Niccoli L, Nannini C, Kaloudi O, Bertoni M, Cassarà E. Cantini F, et al. Among authors: kaloudi o. Int J Rheum Dis. 2010 Oct;13(4):300-17. doi: 10.1111/j.1756-185X.2010.01540.x. Int J Rheum Dis. 2010. PMID: 21199465 Review.
Interstitial lung disease in systemic sclerosis.
Kaloudi O, Miniati I, Alari S, Matucci-Cerinic M. Kaloudi O, et al. Intern Emerg Med. 2007 Dec;2(4):250-5. doi: 10.1007/s11739-007-0075-1. Epub 2007 Dec 17. Intern Emerg Med. 2007. PMID: 18172592 Review.
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O, Giulio Favalli E, Becciolini A, Biggioggero M, Benucci M, Li Gobbi F, Grossi V, Infantino M, Meacci F, Manfredi M, Guiducci S, Bellando-Randone S, Matucci-Cerinic M, Foti R, Di Gangi M, Mosca M, Tani C, Palmieri F, Goletti D; Italian board for the TAilored BIOlogic therapy (ITABIO). Cantini F, et al. Among authors: kaloudi o. Semin Arthritis Rheum. 2016 Apr;45(5):519-32. doi: 10.1016/j.semarthrit.2015.10.001. Epub 2015 Oct 22. Semin Arthritis Rheum. 2016. PMID: 26607440 Review.
Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables.
Niccoli L, Nannini C, Blandizzi C, Mantarro S, Mosca M, Di Munno O, Goletti D, Benucci M, Gobbi FL, Cassarà E, Kaloudi O, Cantini F. Niccoli L, et al. Among authors: kaloudi o. Ther Clin Risk Manag. 2018 Oct 24;14:2097-2111. doi: 10.2147/TCRM.S175772. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 30498353 Free PMC article.
27 results